e-learning
resources
Virtual 2021
06.09.2021
Pathogenic progress in airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Gene expression and genetic variations of HSP70TLR2 and TLR4 in COPD
I. Hlapcic (Zagreb, Croatia), M. Grdic Rajkovic (Zagreb, Croatia), A. Hulina-Tomaškovic (Zagreb, Croatia), S. Popovic-Grle (Zagreb, Croatia), M. Radic Antolic (Zagreb, Croatia), L. Rumora (Zagreb, Croatia)
Source:
Virtual Congress 2021 – Pathogenic progress in airway diseases
Session:
Pathogenic progress in airway diseases
Session type:
E-poster
Number:
2384
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Hlapcic (Zagreb, Croatia), M. Grdic Rajkovic (Zagreb, Croatia), A. Hulina-Tomaškovic (Zagreb, Croatia), S. Popovic-Grle (Zagreb, Croatia), M. Radic Antolic (Zagreb, Croatia), L. Rumora (Zagreb, Croatia). Gene expression and genetic variations of HSP70TLR2 and TLR4 in COPD. 2384
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Gene signalling heterogeneity in exacerbations of COPD determined by microarray analysis of PBMC mRNA
Source: International Congress 2015 – Respiratory translational research: novel mechanisms, diagnostic markers and Space Odyssey
Year: 2015
Gene expression patterns in lung emphysema. A gene microarray analysis
Source: Eur Respir J 2002; 20: Suppl. 38, 87s
Year: 2002
Gene–gene interaction among polymorphisms of
Eotaxin
gene family in Korean asthmatics
Source: Eur Respir J 2005; 26: Suppl. 49, 263s
Year: 2005
Diverse and altered distribution patterns of TLR5 and TLR7 in the distal lung of COPD patients
Source: Annual Congress 2012 - Basic and translational studies in COPD
Year: 2012
Epigenetic changes are associated with altered hBD-1 gene expression in patients with COPD
Source: Annual Congress 2008 - Cell biology of asthma and COPD
Year: 2008
Variation in the TLR4 gene and airway inflammation among patients with COPD
Source: Annual Congress 2009 - Genetics in the smokers corner: from inflammation in smokers via COPD to cancer
Year: 2009
Genetic variability in the IL1RN gene and the balance between IL1-Ra and IL-1β in IPF
Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis
Year: 2011
Microarray gene expression profiles in lung tissue of COPD patients
Source: Eur Respir J 2007; 30: Suppl. 51, 537s
Year: 2007
Gene variants in IL18R1 and IL18RAP are associated with IgE and 25-hydroxy-D3 levels in asthma families
Source: Annual Congress 2008 - Risk factors for childhood asthma and allergy
Year: 2008
Glutathione S-transferase copy number variation alters lung gene expression
Source: Eur Respir J 2011; 37: 15-28
Year: 2011
Gene polymorphisms, gene expression and inflammatory markers in preschool children with and without wheeze
Source: Annual Congress 2012 - Gene-environment treatment and asthma
Year: 2012
Gene expression in CD4+ T-cells reflects heterogeneity in infant wheezing phenotypes
Source: Eur Respir J 2008; 32: 1203-1212
Year: 2008
Microarray gene expression profiling in a murine model of asthma
Source: Annual Congress 2008 - Basic science in asthma and COPD
Year: 2008
The use of microarray analysis of gene signalling to determine heterogeneity of COPD exacerbation phenotypes
Source: ERS Lung Science Conference 2016
Year: 2016
Gene expression profiling in peripheral blood in COPD
Source: Annual Congress 2008 - Novel trends in functional genomics and molecular pathology of neoplastic and non-neoplastic lung diseases
Year: 2008
Investigation for candidate genes of glucocorticoid resistance by genome-wide gene expression profiling in animal model of asthma
Source: Annual Congress 2011 - New mechanisms in airway disease
Year: 2011
Evaluation of mRNA expression profiling of NF-?B mediated signaling in COPD patients.
Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies
Year: 2020
Integrated analysis of COPD gene expression data reveals specific pathway signatures
Source: Annual Congress 2010 - Genetics of obstruction
Year: 2010
Correlation of eotaxin-3 gene expression and other IL-13-induced genes in patients with asthma
Source: Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man
Year: 2021
Candidate surrogate markers for COPD identified by differential gene expression
Source: Eur Respir J 2002; 20: Suppl. 38, 583s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept